Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2011-06-21 Legal Proceedings Report
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
CSL Biotherapies Statement on FDA Warning Letter for GMP 2 pages 63.4KB
Legal Proceedings Report Classification · 95% confidence The document is a press release dated June 22, 2011, regarding an FDA Warning Letter issued to CSL Biotherapies about GMP issues at their Australian influenza vaccine facility. It discusses the FDA inspection, the Warning Letter content, and the company's response and commitment to resolving the issues. There are no financial statements, detailed financial data, or comprehensive report content. The document is a regulatory announcement about compliance and quality issues, not a financial report or management discussion. It is not a report publication announcement since it contains substantive information about the warning letter and company response. This fits best under Legal Proceedings Report (LTR) as it relates to regulatory compliance and enforcement actions by the FDA.
2011-06-21 English
Form 484 Issue and Cancellation of Shares 6 pages 301.4KB
Regulatory Filings
2011-06-16 English
Appendix 3B 7 pages 52.9KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose of the issue, and application for quotation of additional securities on the ASX. It references specific ASX rules and includes sections on quotation agreements and warranties. The content is focused on announcing and providing details about a new share issue rather than presenting financial results, management discussion, or regulatory certifications. This matches the definition of a 'Share Issue/Capital Change' filing, which covers announcements regarding new share issues or capital changes. The document length is over 10,000 characters and contains substantive details, so it is not merely an announcement of a report publication or a regulatory filing. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2011-06-15 English
Correction: Appendix 3B 8 pages 107.3KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form, which is a standard ASX (Australian Securities Exchange) form used for announcing new issues of securities, application for quotation of additional securities, and related agreements. It includes details such as the class and number of securities issued, issue price, purpose of the issue, and quotation agreement. The document is dated 16 June 2011 and is signed by the Company Secretary. It does not contain financial statements, management discussion, or detailed financial results. Instead, it is a regulatory announcement about a capital issuance event. According to the filing definitions, announcements about new share issues or capital changes fall under the category 'Share Issue/Capital Change' (Code: SHA). The document length (11,161 characters) is sufficient to be a full announcement rather than a brief notice. Therefore, the correct classification is SHA with high confidence.
2011-06-15 English
Daily share buy-back notice - Appendix 3E 2 pages 72.6KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules and compliance statements related to a share buy-back program. It provides detailed information about the number of shares bought back, prices paid, and compliance with relevant regulations. This matches the description of a report on the company's repurchase of its own shares. The document length is 2552 characters, which is relatively short but contains substantive data about the buy-back activity, not just an announcement or a link to a report. Therefore, it is classified as a Transaction in Own Shares (POS) filing, which covers reports of the company buying back or selling its own shares.
2011-06-08 English
Final share buy-back notice - Appendix 3F 2 pages 77.1KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3F Final share buy-back notice' and contains detailed information about the company's share buy-back activity, including the number of shares bought back, total consideration paid, and price range. It also includes a compliance statement related to the Corporations Act. The document is relatively short (1783 characters) and focuses on reporting the completion of a share buy-back program. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buyback of its own shares. There is no indication that this is an announcement of a report or a certification, so it is not classified as RPA or RNS. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2011-06-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.